Etoposide Injection, Solution, Concentrate
Product Images NDC 71288-177

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 71288-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 100 mg per 5 mL Carton Label)

This text appears to be a description of a medication. It includes information about the composition per mL, containing 20 mg etoposide, USP, citric acid anhydrous, polysorbate 80, and dehydrated alcohol among other ingredients. The dosage instructions are provided on the package insert. The medication is advised to be stored at a temperature between 20°C to 25°C and should not be frozen. It mentions the manufacturer and where it is made, China.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 100 mg per 5 mL Vial Label)

This text provides information about a medication called Etoposide Injection, USP. It contains 100mg per 5mL, with a concentration of 20mg per mL. The National Drug Code (NDC) for this medication is 71288-175-05.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 1 gram per 50 mL Carton Label)

This text appears to be a description of a medication called Etoposide. It contains information about the composition of the drug, including the amounts of different ingredients like etoposide, citric acid, polysorbate 80, and others. The dosage instructions and storage conditions are also provided. The medication is labeled as "Etoposide Injection, USP" and is highlighted as cytotoxic. The text also mentions that it is free from natural rubber latex. The product seems to be manufactured in Chengdu, China.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 1 gram per 50 mL Vial Label)

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 500 mg per 25 mL Carton Label)

This text appears to be a description of a pharmaceutical product. It mentions the composition which includes 20 mg etopaside, USP, 2 mg citric acid anhydrous, 80 mg polysorbate 80, 650 mg polyethylene glycol 300, and 262 mg dehydrated alcohol. The product is sterile, nonpyrogenic, and preservative-free. It should be stored at 20-25°C and should not be frozen. The manufacturer is Meitheal Pharmaceuticals and the product is made by Kindos Pharmaceuticals Co., Ltd.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 500 mg per 25 mL Vial Label)

This text is outlining information about a medication called Etopos, which comes in a 25 mL multiple-dose vial with 500 mg per 25 ml (20 mg per ml). It provides important instructions that the medication must be diluted before intravenous infusion. The product is associated with the NDC code 71288-176-25.*

FDA Label Image

Structural Formula (Etoposide Structure)

The text provided contains information about a chemical compound with the formula CaaH:O1s and a molecular weight of 588.56. This information could be related to a specific chemical or substance in a scientific context.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.